GlobeVerge
WORLD
Owkin signs AI drug discovery deal with Boehringer for cancer, immunology
Owkin signs AI drug discovery deal with Boehringer for cancer, immunology
Read more on CNA
More in Technology
- Meta's $18 billion settlement could clear the way for a wave of new AI products, analysts say
- Axis Communications Opens Montreal Experience Center, Delivering Innovation Directly to Customers
- Nvidia CEO urges G20 to avoid AI rules on 'theoretical' harms
- Commerce Secretary Howard Lutnick says data center protesters are falling for 'propaganda'